NVAX
Novavax Inc
Price:  
14.40 
USD
Volume:  
17,291,334.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Novavax EV/EBITDA

-401.7%
Upside

As of 2024-06-16, the EV/EBITDA ratio of Novavax Inc (NVAX) is -5.49. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Novavax's latest enterprise value is 1,770.79 mil USD. Novavax's TTM EBITDA according to its financial statements is -322.79 mil USD. Dividing these 2 quantities gives us the above Novavax EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 14.4x - 21.5x 17.0x
Forward P/E multiples 16.6x - 30.7x 22.3x
Fair Price (36.46) - (47.68) (43.44)
Upside -353.2% - -431.1% -401.7%
14.40 USD
Stock Price
(43.44) USD
Fair Price

Novavax EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-06-14 -5.49
2024-06-13 -5.77
2024-06-12 -6.12
2024-06-11 -6.50
2024-06-10 -6.18
2024-06-07 -7.13
2024-06-06 -7.73
2024-06-05 -8.34
2024-06-04 -6.95
2024-06-03 -7.15
2024-05-31 -5.76
2024-05-30 -5.86
2024-05-29 -5.79
2024-05-28 -5.97
2024-05-24 -5.96
2024-05-23 -5.81
2024-05-22 -6.05
2024-05-21 -5.71
2024-05-20 -5.66
2024-05-17 -4.88
2024-05-16 -5.49
2024-05-15 -4.83
2024-05-14 -5.09
2024-05-13 -4.92
2024-05-10 -3.08
2024-05-09 -1.17
2024-05-08 -1.17
2024-05-07 -1.23
2024-05-06 -1.29
2024-05-03 -1.37
2024-05-02 -1.27
2024-05-01 -1.25
2024-04-30 -1.11
2024-04-29 -1.09
2024-04-26 -1.00
2024-04-25 -0.94
2024-04-24 -1.03
2024-04-23 -1.04
2024-04-22 -0.99
2024-04-19 -0.95
2024-04-18 -0.91
2024-04-17 -0.91
2024-04-16 -0.96
2024-04-15 -1.01
2024-04-12 -1.08
2024-04-11 -1.09
2024-04-10 -1.07
2024-04-09 -1.14
2024-04-08 -1.15
2024-04-05 -1.14